Goh BC - Search Results

1

Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer.

Liu C, Xiang X, Han S, Lim HY, Li L, Zhang X, Ma Z, Yang L, Guo S, Soo R, Ren B, Wang L, Goh BC. Liu C, et al. Among authors: goh bc. Cancer Lett. 2022 Jan 1;524:91-102. doi: 10.1016/j.canlet.2021.10.013. Epub 2021 Oct 14. Cancer Lett. 2022. PMID: 34656690 Review.

2

Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients.

Lee HS, Goh BC, Fan L, Khoo YM, Wang L, Lim R, Ong AB, Chua C. Lee HS, et al. Among authors: goh bc. Br J Clin Pharmacol. 2003 Mar;55(3):270-7. doi: 10.1046/j.1365-2125.2003.01767.x. Br J Clin Pharmacol. 2003. PMID: 12630977 Free PMC article.

3

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.

Soo RA, Lim HL, Wang LZ, Lee HS, Millward MJ, Tok LT, Lee SC, Lehnert M, Goh BC. Soo RA, et al. Among authors: goh bc. Cancer Chemother Pharmacol. 2003 Aug;52(2):153-8. doi: 10.1007/s00280-003-0637-5. Epub 2003 May 16. Cancer Chemother Pharmacol. 2003. PMID: 12750842 Clinical Trial.

4

A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma.

Wang LZ, Goh BC, Grigg ME, Lee SC, Khoo YM, Lee HS. Wang LZ, et al. Among authors: goh bc. Rapid Commun Mass Spectrom. 2003;17(14):1548-52. doi: 10.1002/rcm.1091. Rapid Commun Mass Spectrom. 2003. PMID: 12845579

5

An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography.

Wang LZ, Goh BC, Lee HS, Noordhuis P, Peters GJ. Wang LZ, et al. Among authors: goh bc. Ther Drug Monit. 2003 Oct;25(5):552-7. doi: 10.1097/00007691-200310000-00003. Ther Drug Monit. 2003. PMID: 14508377

6

Sensitive high-performance liquid chromatography/mass spectrometry method for determination of steviol in rat plasma.

Wang LZ, Goh BC, Fan L, Lee HS. Wang LZ, et al. Among authors: goh bc. Rapid Commun Mass Spectrom. 2004;18(1):83-6. doi: 10.1002/rcm.1285. Rapid Commun Mass Spectrom. 2004. PMID: 14689563

7

Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma.

Kumar MB, Lu JJ, Loh KS, Chong LM, Soo R, Goh BC, Tan KS, Shakespeare TP. Kumar MB, et al. Among authors: goh bc. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):688-93. doi: 10.1016/S0360-3016(03)01618-3. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967421

8

Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression.

Soo R, Putti T, Tao Q, Goh BC, Lee KH, Kwok-Seng L, Tan L, Hsieh WS. Soo R, et al. Among authors: goh bc. Arch Otolaryngol Head Neck Surg. 2005 Feb;131(2):147-52. doi: 10.1001/archotol.131.2.147. Arch Otolaryngol Head Neck Surg. 2005. PMID: 15723947

9

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma.

Lee SC, Lim SG, Soo R, Hsieh WS, Guo JY, Putti T, Tao Q, Soong R, Goh BC. Lee SC, et al. Among authors: goh bc. Pharmacogenet Genomics. 2006 Jan;16(1):73-4. doi: 10.1097/01.fpc.0000184959.82903.02. Pharmacogenet Genomics. 2006. PMID: 16344724

10

Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug.

Tham LS, Lee HS, Wang L, Yong WP, Fan L, Ong AB, Sukri N, Soo R, Lee SC, Goh BC. Tham LS, et al. Among authors: goh bc. Ther Drug Monit. 2006 Apr;28(2):255-61. doi: 10.1097/01.ftd.0000194497.55269.d9. Ther Drug Monit. 2006. PMID: 16628140 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters